Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 21, Issue 8, Pages 1036-1044
Publisher
SAGE Publications
Online
2014-11-13
DOI
10.1177/1352458514556296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
- (2014) Clemens Warnke et al. ANNALS OF NEUROLOGY
- JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis
- (2014) Spyridon Chalkias et al. ANNALS OF NEUROLOGY
- Lymphocyte Gene Expression and JC Virus Noncoding Control Region Sequences Are Linked with the Risk of Progressive Multifocal Leukoencephalopathy
- (2014) L. J. Marshall et al. JOURNAL OF VIROLOGY
- MiR-126: a novel route for natalizumab action?
- (2014) Maria Meira et al. Multiple Sclerosis Journal
- Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study
- (2014) R Mancuso et al. Multiple Sclerosis Journal
- JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants
- (2014) Emilie Sundqvist et al. PLoS Pathogens
- JC Virus in CD34+and CD19+Cells in Patients With Multiple Sclerosis Treated With Natalizumab
- (2014) Elliot M. Frohman et al. JAMA Neurology
- Central Nervous System Herpes Simplex and Varicella Zoster Virus Infections in Natalizumab-Treated Patients
- (2013) A. J. Fine et al. CLINICAL INFECTIOUS DISEASES
- Changes to anti-JCV antibody levels in a Swedish national MS cohort
- (2013) Clemens Warnke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients
- (2013) Rebecca C Selter et al. Multiple Sclerosis Journal
- Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis
- (2013) C. Warnke et al. NEUROLOGY
- Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy
- (2012) A Harrer et al. Multiple Sclerosis Journal
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natalizumab and Impedance of the Homing of CD34+ Hematopoietic Progenitors
- (2011) Christian Saure ARCHIVES OF NEUROLOGY
- Frequency and Large T (LT) Sequence of JC Polyomavirus DNA in Oligodendrocytes, Astrocytes and Granular Cells in Non-PML Brain
- (2011) Julianne Bayliss et al. BRAIN PATHOLOGY
- Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
- (2011) Raquel Planas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Sequencing and Analysis of JC Virus DNA From Natalizumab-Treated PML Patients
- (2011) Carl E. Reid et al. JOURNAL OF INFECTIOUS DISEASES
- Progressive Multifocal Leukoencephalopathy (PML) Development Is Associated With Mutations in JC Virus Capsid Protein VP1 That Change Its Receptor Specificity
- (2011) Leonid Gorelik et al. JOURNAL OF INFECTIOUS DISEASES
- Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells
- (2011) Andrea Harrer et al. JOURNAL OF NEUROIMMUNOLOGY
- Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
- (2011) Mario Skarica et al. JOURNAL OF NEUROIMMUNOLOGY
- Natalizumab and Progressive Multifocal Leukoencephalopathy
- (2010) Clemens Warnke et al. ARCHIVES OF NEUROLOGY
- CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function
- (2010) D Jing et al. BONE MARROW TRANSPLANTATION
- CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus
- (2010) Clemens Warnke et al. Multiple Sclerosis Journal
- Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab
- (2008) Maria del Pilar Martin ARCHIVES OF NEUROLOGY
- The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans
- (2008) F. Zohren et al. BLOOD
- Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients
- (2008) S HOUFF et al. JOURNAL OF NEUROIMMUNOLOGY
- Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients
- (2008) Raija L.P. Lindberg et al. JOURNAL OF NEUROIMMUNOLOGY
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- (2008) M. Krumbholz et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More